Workflow
Standby Equity Purchase Agreement
icon
Search documents
SunPower Secures $20 Million SEPA Agreement
Globenewswire· 2026-02-02 13:00
Core Insights - SunPower Inc. has secured a Standby Equity Purchase Agreement (SEPA) with Yorkville Advisors Global for $20 million in funding through newly issued stock [1] - The SEPA includes a pre-paid advance feature, providing financial flexibility without diluting investors or triggering interest payments on unused portions [2] - CEO T.J. Rodgers stated that this SEPA is part of a strategy to maintain a minimum cash balance of $10 million each quarter, following a recent $55 million Equity Line of Credit from White Lion Capital [3] - The company is pursuing an additional $30 million equity offering to achieve cash flow self-sufficiency by Q4 2026, while maintaining non-GAAP quarterly operating income profitability throughout 2026 [3] Company Overview - SunPower Inc. is a leading residential solar services provider in North America, offering digital platforms and installation services to support energy-efficient lifestyles [4]
RedHill Biopharma(RDHL) - Prospectus(update)
2026-01-22 21:04
Israel 2834 Not Applicable (Primary Standard Industrial Classification Code Number) As filed with the Securities and Exchange Commission on January 22, 2026 Registration No. 333-292528 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REDHILL BIOPHARMA LTD. (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) (State or other jurisdiction o ...
RedHill Biopharma(RDHL) - Prospectus
2025-12-31 22:09
Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 As filed with the Securities and Exchange Commission on December 31, 2025 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REDHILL BIOPHARMA LTD. (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) (Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices) RedHill Biopharma In ...
Inspira Technologies Oxy B.H.N. .(IINN) - Prospectus
2025-12-22 21:27
As filed with the Securities and Exchange Commission on December 22, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INSPIRA TECHNOLOGIES OXY B.H.N.LTD. (Exact name of registrant as specified in its charter) State of Israel 3841 Not Applicable (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Nu ...
Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution - Inspira Technologies Oxy (NASDAQ:IINN
Benzinga· 2025-12-15 13:30
Core Viewpoint - Inspira Technologies has announced a definitive agreement for a registered direct offering of ordinary shares, aiming to raise approximately $1.8 million to support its strategic initiatives and operations [1][2][6]. Group 1: Registered Direct Offering - The company will issue and sell 1,565,217 ordinary shares at a price of $1.15 per share, resulting in gross proceeds of about $1.8 million [2]. - The offering is expected to close on or about December 16, 2025, pending customary closing conditions [2]. Group 2: Standby Equity Purchase Agreement (SEPA) - Inspira has entered into a SEPA with YA, allowing the company to sell up to $25 million of its ordinary shares over a 36-month period at its discretion [4]. - There are no minimum purchase requirements under the SEPA, and the company is not obligated to draw on this facility [4][9]. Group 3: Use of Proceeds - The net proceeds from the registered direct offering and any future proceeds from the SEPA will be used for working capital and general corporate purposes, specifically to support the company's strategic roadmap and planned operations [6]. Group 4: Company Overview - Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions, with products like the INSPIRA™ ART100 system and the upcoming INSPIRA ART500 [8]. - The company is positioned as an attractive platform within the life-support and MedTech landscape, supported by a growing IP portfolio and multiple cleared products [8].
Nuburu(BURU) - Prospectus
2025-12-12 22:11
Table of Contents As filed with the Securities and Exchange Commission on December 12, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 NUBURU, INC. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 3690 85-1288435 (I.R.S. Employer Identification Number) 44 Cook ...
Nomadar(NOMA) - Prospectus
2025-11-24 16:55
As filed with the Securities and Exchange Commission on November 21, 2025 Registration No. 333-[_] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NOMADAR CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 7900 99-3383359 (I.R.S. Employer Identification Number) 5015 Highway 59 N Mars ...
Scinai Immunotherapeutics .(SCNI) - Prospectus
2025-09-22 14:47
(Primary Standard Industrial Classification Code Number) Israel 2836 Not Applicable As filed with the United States Securities and Exchange Commission on September 22, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Scinai Immunotherapeutics Ltd. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Copies of all communications, ...
BiondVax Pharmaceuticals Ltd.(BVXV) - Prospectus
2025-09-22 14:47
FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Scinai Immunotherapeutics Ltd. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Israel 2836 Not Applicable As filed with the United States Securities and Exchange Commission on September 22, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (I.R.S. Employer Identificatio ...
Icon Energy Corp.(ICON) - Prospectus(update)
2025-09-17 18:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Icon Energy Corp. (Exact name of Registrant as specified in its charter) Republic of the Marshall Islands As filed with the U.S. Securities and Exchange Commission on September 17, 2025. Registration No. 333-290206 (State or other jurisdiction of incorporation or organization) 4412 (Primary Standard Industrial Classification Code Number) N/A (I.R.S. Empl ...